Latest News about MRNA
Recent news which mentions MRNA
Moderna CEO Sells Shares, Deletes Social Media: What You Need To Know
February 14, 2022
Tickers
MRNA
From Benzinga
32 Stocks Moving In Monday's Mid-Day Session
February 14, 2022
From Benzinga
Why Pfizer, BioNTech, Moderna, and Novavax Stocks Are Sliding Today
February 14, 2022
From Motley Fool
From MarketWatch
Breaking Down Pfizer and Moderna's Omicron-Specific Vaccine Trials
February 12, 2022
From Motley Fool
5 Struggling Stocks to Buy at a Discount
February 12, 2022
From Motley Fool
2 Beaten-Down Growth Stocks to Buy and Hold for a Decade
February 11, 2022
From Motley Fool
From Benzinga
1 Green Flag For Novavax in 2022, and 1 Red Flag
February 11, 2022
From Motley Fool
Everyone Is Talking About This Stock. Is It a Good Long-Term Option?
February 11, 2022
Tickers
MRNA
From Motley Fool
Elon Musk Elected Into The National Academy Of Engineering
February 10, 2022
From Benzinga
Novavax Stock Is a Buy After This Overdone Sell-Off
February 09, 2022
From InvestorPlace
Down 52% In 3 Months, Is Moderna Stock a Bargain Buy?
February 09, 2022
From Motley Fool
Better Buy: Moderna vs. Novavax
February 09, 2022
From Motley Fool
Why Moderna Stock Lost 33% in January
February 08, 2022
From Motley Fool
AMD And Pinduoduo Lead The Nasdaq Higher
February 08, 2022
From Benzinga
Take a Leap Into Novavax Stock After Vaccine Sales Start
February 08, 2022
From InvestorPlace
NVAX Stock Alert: Why Is Novavax Plunging Today?
February 08, 2022
From InvestorPlace
From Benzinga
These 15 stocks rose 100% or more during the pandemic, but they’ve since been crushed. Is it now time to buy?
February 08, 2022
From MarketWatch
Are Intranasal Sprays The Next $36 Billion Trend in Vaccine Stocks?
February 08, 2022
From Motley Fool
Moderna And 4 Other Stocks Sold By Insiders
February 07, 2022
From Benzinga
Is it Too Late to Buy Vaccine Stocks?
February 07, 2022
From Motley Fool
From Motley Fool
From Benzinga
4 Stocks That Moved the Market in January
February 05, 2022
From Motley Fool
Is It Time to Buy the S&P 500's 3 Worst-Performing January Stocks?
February 04, 2022
From Motley Fool
Is It Time to Buy the S&P 500's 4 Worst-Performing Stocks?
February 04, 2022
From Motley Fool
Germany's Vaccine Commission Recommends Novavax's COVID-19 Vaccine For Adults: Reuters
February 04, 2022
From Benzinga
6 Stocks That Could Soar If New Coronavirus Variants Emerge
February 04, 2022
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.